Development and biological evaluation of C(60) fulleropyrrolidine-thalidomide dyad as a new anti-inflammation agent.

Research studies in the field of C(60) fullerene derivatives have significantly increased due to the broad range of biological activities that were found for these compounds. We designed and prepared a new C(60) fullerene hybrid bearing thalidomide as a potential double-action anti-inflammatory agent, capable of simultaneous inhibition of LPS-induced NO and TNF-alpha production. The C(60) fulleropyrrolidine-thalidomide dyad, CLT, was an effective agent to suppress the release of NO and TNF-alpha by the LPS-stimulated macrophages RAW 264.7. Ten micromolars of CLT effectively inhibited LPS-induced NO and TNF-alpha production by 47.3+/-4.2% and 70.2+/-4% with respected to the control, respectively. Furthermore, preliminary biochemical investigation revealed that CLT was a potent agent to suppress both LPS-induced intracellular ROS production and iNOS expression, and CLT also inhibited the phosphorylation of ERK which is an important protein kinase involved in the activation of TNF-alpha synthesis in LPS-activated macrophages. We believed that the studies herein would hold promise for future development of a new generation of potent anti-inflammatory agents.

[1]  Chun‐Mao Lin,et al.  Structure-activity relationship of C6-C3 phenylpropanoids on xanthine oxidase-inhibiting and free radical-scavenging activities. , 2007, Free radical biology & medicine.

[2]  Ravindra G. Kulkarni,et al.  Novel targets for antiinflammatory and antiarthritic agents. , 2006, Current pharmaceutical design.

[3]  M. Prato,et al.  Novel versatile fullerene synthons. , 2001, The Journal of organic chemistry.

[4]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[5]  A. Barron,et al.  Fullerene-derivatized amino acids: synthesis, characterization, antioxidant properties, and solid-phase peptide synthesis. , 2007, Chemistry.

[6]  D. Guldi.  Molecular porphyrinfullerene architectures , 2003 .

[7]  S. Fukuzumi,et al.  Porphyrin‐ and Fullerene‐Based Molecular Photovoltaic Devices , 2004 .

[8]  R. Billings,et al.  Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants. , 1996, Molecular pharmacology.

[9]  T. Nagano,et al.  INHIBITORY EFFECTS OF FULLERENE C60 DERIVATIVES ON ENDOTHELIUM-DERIVED RELAXATION IN RABBIT THORACIC AORTA , 2001 .

[10]  K. Ishihara,et al.  Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. , 2003, Free radical biology & medicine.

[11]  K. Preston,et al.  Radical Reactions of C60 , 1991, Science.

[12]  E. Nakamura,et al.  Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience. , 2003, Accounts of chemical research.

[13]  H. Pfander,et al.  C45- und C50-Carotinoide. 5. Mitteilung , 1986 .

[14]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[15]  H. Fang,et al.  Synthesis and anti-inflammation evaluation of new C60 fulleropyrrolidines bearing biologically active xanthine. , 2008, Bioorganic & medicinal chemistry letters.

[16]  J. Cho,et al.  Inhibitory effect of lignans from the rhizomes ofCoptis japonica var.dissecta on tumor necrosis factor-α production in lipopolysaccharide-stimulated RAW264.7 cells , 1998, Archives of pharmacal research.

[17]  Magda Melchert,et al.  The thalidomide saga. , 2007, The international journal of biochemistry & cell biology.

[18]  T. Prindiville,et al.  The biology of TNF blockade. , 2003, Autoimmunity reviews.

[19]  Yukihiro Goda,et al.  Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2-* versus 1O2. , 2003, Journal of the American Chemical Society.

[20]  M Satoh,et al.  Effects of acute and short-term repeated application of fullerene C60 on agonist-induced responses in various tissues of guinea pig and rat. , 1995, General pharmacology.

[21]  Jodie L. Conyers,et al.  Self assembly of amphiphilic C60 fullerene derivatives into nanoscale supramolecular structures , 2007, Journal of nanobiotechnology.

[22]  Stephen R. Wilson,et al.  [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. , 2005, Nano letters.

[23]  S. Wnendt,et al.  Synthesis and immunological activity of water-soluble thalidomide prodrugs. , 2001, Bioorganic & medicinal chemistry.

[24]  G. Kollias,et al.  TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway , 2000, Cell.

[25]  Sheng-Tung Huang,et al.  A Novel Bis‐aziridinylnaphthoquinone with Anti‐Solid Tumor Activity in which Induced Apoptosis is Associated with Altered Expression Of Bcl‐2 Protein , 2004, Chembiochem : a European journal of chemical biology.

[26]  A. Barron,et al.  The use of fullerene substituted phenylalanine amino acid as a passport for peptides through cell membranes. , 2007, Organic & biomolecular chemistry.

[27]  G. Pirri,et al.  Synthesis of novel [60]fullerene–flavonoid dyads , 2002 .

[28]  A. Tomé,et al.  [60]Fullerene–flavonoid dyads , 2004 .

[29]  Zhen Hu,et al.  Synthesis of amphiphilic amino acid C60 derivatives and their protective effect on hydrogen peroxide-induced apoptosis in rat pheochromocytoma cells , 2008 .

[30]  T. Mashino,et al.  Inhibitory effects of a fullerene derivative, dimalonic acid C60, on nitric oxide-induced relaxation of rabbit aorta. , 1997, European journal of pharmacology.

[31]  S. Devaraj,et al.  Oxidative Stress, Inflammation, and Diabetic Vasculopathies: The Role of Alpha Tocopherol Therapy , 2002, Free radical research.

[32]  M. Prato,et al.  Synthesis and Molecular Modeling Studies of Fullerene−5,6,7‐Trimethoxyindole−Oligonucleotide Conjugates as Possible Probes for Study of Photochemical Reactions in DNA Triple Helices , 2002 .

[33]  A. Tomé,et al.  Synthesis of [60]fullerene-quercetin dyads , 2002 .